Eli Lilly to Acquire Ajax Therapeutics in Deal Worth Up to $2.3 Billion
Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion, strengthening its pipeline in blood cancer treatments.
#Pharma
Explore MarketSpeaker's latest reporting, research, and expert analysis tagged with "pharma", collected in one continuously updated archive.
Related Posts
Sun Pharma Shares Jump 7% on $11.75 Billion Organon Acquisition
Sun Pharma shares rose 7% after announcing an $11.75 billion deal to acquire U.S.-based Organon, expanding its global footprint.
Eli Lilly Becomes First Health-Care Company to Reach $1 Trillion Market Value
Eli Lilly crossed a $1 trillion market capitalization for the first time, powered by booming demand for its diabetes and weight-loss drugs.